Skip to main content
SpringerLink
Log in

Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Beta-adrenergic receptors mediate the inhibitory influence of cathecolamines on GH secretion, probably via the stimulation of hypothalamic somatostatin release. Accordingly, beta-adrenergic agonists and antagonists inhibit and increase, respectively, the GH response to many stimuli, including GHRH, in man. Aim of the present study was to verify the effect, if any, of beta-adrenergic drugs on the GH response to Hexarelin, a synthetic GH-releasing hexapeptide. Interestingly, the GH-releasing effect of Hexarelin has been reported to be partially refractory to neuroendocrine manipulations known to strongly enhance or abolish the GHRH-induced GH release. In 6 normal male volunteers (aged 22–27 yr) we studied the interaction of the maximally effective iv dose of Hexarelin (HEX, 2 μg/kg iv at 0 min) with atenolol (100 mg po at −60 min) or salbutamol (0.08 mg/kg po at - 60 min), which are beta-adrenergic antagonist and agonist, respectively. HEX induced a marked GH rise(AUC, mean ± SE: 4573.2±588.8 μg.min/L), which was unchanged by atenolol (4706.2±928.2 μg.min/L) but blunted by salbutamol (2792.8±618.0 μg.min/L, p<0.03). In conclusion, present data show that, in man, the GH-releasing effect of Hexarelin is not enhanced by beta-adrenergic blockade while is only blunted by the activation of beta receptors. According to other data, these results indicate that the potent GH-releasing activity of Hexarelin is, at least partially, refractory to beta-adrenergic-mediated manipulations of somatostatinergic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ghigo E. Neurotransmitter control of growth hormone secretion. In: De la Cruz L.F. (Ed.), Regulation of growth hormone and somatic growth. Excerpta Medica, Amsterdam, 1992, p. 103.

    Google Scholar 

  2. Chihara K., Kodama H., Kaji H., Kashio Y., Okimara Y., Abe H., Fujita T. Augmentation by propranolol of growth hormone releasing hormone (1–44) NH2-induced growth hormone release in normal short and normal children. J. Clin. Endocrinol. Metab. 61: 229, 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Mauras N., Blizzard R.M., Thorner M.O., Rogol A.D. Selective ß1 adrenergic receptor blockade with atenolol enhances growth hormone-releasing hormone-mediated growth hormone release in man. Metabolism 36: 369, 1987.

    Article  PubMed  CAS  Google Scholar 

  4. Martha P.M. Jr, Blizzard R.M., Rogol A.D. Atenolol enhanced growth hormone release to exogenous nocturnal growth hormone secretion in boys with constitutional delay of growth. Pediatr. Res. 23: 393, 1988.

    Article  PubMed  Google Scholar 

  5. Ghigo E., Bellone J., Arvat E., Mazza E., Cella S.G., Brambilla F., Muller E.E., Camanni F. Effects of alpha and beta adrenergic agonists and antagonists on growth hormone secretion in man. J. Neuroendocrinol. 2: 473, 1990.

    Article  PubMed  CAS  Google Scholar 

  6. Ghigo E., Arvat E., Gianotti L., Ramunni J., Maccario M., Camanni F. Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. Clin. Endocrinol. (Oxf.) 40: 799, 1994.

    Article  CAS  Google Scholar 

  7. Arvat E., Ramunni J., Gianotti L., Di Vito L., Maccario M., Camanni F., Ghigo E. Interaction of salbutamol and galanin on both basal and GHRH-stimulated GH secretion in humans. J. Endocrinol. Invest. 18: 324, 1995.

    Article  PubMed  CAS  Google Scholar 

  8. Bowers C.Y., Momany F.A., Reynolds G.A., Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114: 1537, 1984.

    Article  PubMed  CAS  Google Scholar 

  9. Clark R.G., Carlsson M.S., Trojnar J., Robinson I.C.A.F. The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J. Neuroendocrinol. 1: 252, 1989.

    Article  Google Scholar 

  10. Ilson B.E., Jorkasky D.K., Cumow R.T., Stote R.M. Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. J. Clin. Endocrinol. Metab. 69: 212, 1989.

    Article  PubMed  CAS  Google Scholar 

  11. Bowers C.Y., Reynolds G.A., Durham D., Barrera C.M., Pezzoli S.S., Thorner M.O. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J. Clin. Endocrinol. Metab. 70: 975, 1990.

    Article  PubMed  CAS  Google Scholar 

  12. Ghigo E., Arvat E., Gianotti L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Growth hormone-releasing activity of Hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal and oral administration in man. J. Clin. Endocrinol. Metab. 78: 693, 1994.

    PubMed  CAS  Google Scholar 

  13. Momany F., Bowers C.Y., Reynolds G.A., Hong A., Newlander K. Conformational energy studies and in vitro and in vivo activity data on growth hormone-releasing peptides. Endocrinology 114: 1531, 1984.

    Article  PubMed  CAS  Google Scholar 

  14. Bowers C.Y., Sartor A.O., Reynolds G.A., Badger T.M. On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology 128: 2027, 1991.

    Article  PubMed  CAS  Google Scholar 

  15. Badger T.M., Millard W.Y., McCormik G.F., Bowers C.Y., Martin J.B. The effects of growth hormone (GH)-releasing peptides on GH secretion in perifused pituitary cells of adult male rats. Endocrinology 115: 1432, 1984.

    Article  PubMed  CAS  Google Scholar 

  16. Sartor O., Bowers C.Y., Chang D. Parallel studies of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 in rat primary pituitary cell monolayer culture. Endocrinology 116: 952, 1985.

    Article  PubMed  CAS  Google Scholar 

  17. Cheng K., Chan W.W.S., Barreto A., Convey E.M., Smith R.G. The synergistic effects of His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′,5′-monophosphate accumulation in rat primary cell culture. Endocrinology 124: 2791, 1989.

    Article  PubMed  CAS  Google Scholar 

  18. Goth M.I., Lyons C.E., Canny B.Y., Thorner M.O. Pituitary adenilate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130: 939, 1992.

    PubMed  CAS  Google Scholar 

  19. Codd E.E., Shu A.Y.L., Walker R.F. Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology 28: 1139, 1989.

    Article  PubMed  CAS  Google Scholar 

  20. Veeraragan K., Sethumadhavan K., Bowers C.Y. Growth hormone-releasing peptide (GHRP) binding to porcine anterior-pituitary and hypothalamic membranes. Life Sci. 50: 1149, 1992.

    Article  Google Scholar 

  21. Deghenghi R., Boutignon F., Wuthrich P., Lenaerts V., Imbimbo B., Lucchelli P.E., Locatelli V., Battisti C., Cananzi M., Muller E.E. GH releasing properties of hexarelin (EP 23905). International Symposium on Growth Hormone II: Basic and Clinical Aspects. Tarpon Springs, Florida, 1992, p. 31, (Abstract).

    Google Scholar 

  22. Conley L.C., Giustina A., Imbimbo B.P., Stagg L.C., Deghenghi R., Weherenberg W.B. Hexarelin [His-D-2-Methyl-Trp-Ala-Trp-D-Phe-Lys-NH2], a novel GH-releasing peptide, is biologically active in male and female rats. Endocrine 2: 691, 1994.

    CAS  Google Scholar 

  23. Deghenghi R., Cananzi M., Torsello A., Battisti C., Muller E.E., Locatelli V. GH-releasing activity of hexarelin, a new growth hormone releasing peptide, in infant and adult rats. Life Sci. 54: 1321, 1994.

    Article  PubMed  CAS  Google Scholar 

  24. Arvat E., Gianotti L., Di Vito L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 61: 51, 1995.

    Article  PubMed  CAS  Google Scholar 

  25. Maccario M., Arvat E., Procopio M., Gianotti L., Grottoli S., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism 1: 134, 1995.

    Article  Google Scholar 

  26. Penalva A., Pombo M., Carballo A., Barreiro J., Casanueva F.F., Dieguez C. Influence of sex, age and adrenergic pathways on the growth hormone response to GHRP-6. Clin. Endocrinol. (Oxf.) 38: 87, 1993.

    Article  CAS  Google Scholar 

  27. Malozowsky S., Hao E.N., Ren S.G., Marin G., Liu L., Southers J.L., Merriam G.R. Growth hormone (GH) responses to the hexapeptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non GHRH-mediated responses. J. Clin. Endocrinol. Metab. 73: 314, 1991.

    Article  Google Scholar 

  28. Samols E., Weir G.C., Ranseur R., Day J.A., Patel Y.C. Modulation of pancreatic somatostatin by adrenergic and cholinergic agonism and by hyperglycemic sulfonamides. Metabolism 9 (Suppl 1): 1219, 1978.

    Article  Google Scholar 

  29. Krieg R.J., Perkins S.N., Johnson J.H., Rogers J.P., Arimura A., Cronin M.J. ß Adrenergic stimulation of growth hormone (GH) release in vivo and subsequent inhibition of GH releasing factor-induced GH secretion. Endocrinology 122: 531, 1988.

    Article  PubMed  CAS  Google Scholar 

  30. Richardson S.B., Twente S. Inhibition of hypothalamic somatostatin release by ß adrenergic antagonist. Endocrinology 126: 1043, 1990.

    Article  PubMed  CAS  Google Scholar 

  31. Kelijman M., Frohman L. ß-adrenergic modulation of growth hormone (GH) autofeedback on sleep-associated and pharmacologically induced GH secretion. J. Clin. Endocrinol. Metab. 69: 1187, 1989.

    Article  PubMed  CAS  Google Scholar 

  32. Arosio M., Losa M., Bazzoni N., Bochicchio D., Palmieri E., Nava C., Faglia G. Effects of propranolol on GH responsiveness to repeated GH-releasing hormone stimulation in normal subjects. Acta Endocrinol. (Copenh.) 122: 1, 1990.

    Google Scholar 

  33. Hao E.H., Malozowsky S., Ren S.G., Marin G., Southers J., Merriam G. A comparison of the effects of GH-releasing hormone (GHRH) and GH-releasing peptide (GHRP) on GH and somatostatin (SRIF) release. Proc. 70th Ann. Meet. Endocr. Soc. New Orleans, Louisiana, p. 304, 1988 (abstract).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Endocrinologia, Dipartimento di Fisiopatologia Clinica, University of Torino, Torino, Italy

    E. Arvat, L. Gianotti, J. Ramunni, L. DiVito, F. Camanni & E. Ghigo M.D.

  2. Europeptides, Argenteuil, France

    R. Deghenghi

Authors
  1. E. Arvat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. Gianotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Ramunni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. DiVito
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Deghenghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F. Camanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. E. Ghigo M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arvat, E., Gianotti, L., Ramunni, J. et al. Influence of beta-adrenergic agonists and antagonists on the GH-releasing effect of Hexarelin in man. J Endocrinol Invest 19, 25–29 (1996). https://doi.org/10.1007/BF03347854

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347854

Key-words

Search

Navigation